Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925197.RAyL1cHE1zuTCNtS2qD-TxqXT-jvqbPRzgTcCtz2CZ_Pc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925197.RAyL1cHE1zuTCNtS2qD-TxqXT-jvqbPRzgTcCtz2CZ_Pc130_assertion type Assertion NP925197.RAyL1cHE1zuTCNtS2qD-TxqXT-jvqbPRzgTcCtz2CZ_Pc130_head.
- NP925197.RAyL1cHE1zuTCNtS2qD-TxqXT-jvqbPRzgTcCtz2CZ_Pc130_assertion description "[Other BRCA-associated cancers have been shown to have greater sensitivity to platinum and poly(ADP-ribose) polymerase (PARP) inhibitors with better clinical outcomes than in sporadic cases; however, outcomes in BRCA-associated PAC have not been reported.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925197.RAyL1cHE1zuTCNtS2qD-TxqXT-jvqbPRzgTcCtz2CZ_Pc130_provenance.
- NP925197.RAyL1cHE1zuTCNtS2qD-TxqXT-jvqbPRzgTcCtz2CZ_Pc130_assertion evidence source_evidence_literature NP925197.RAyL1cHE1zuTCNtS2qD-TxqXT-jvqbPRzgTcCtz2CZ_Pc130_provenance.
- NP925197.RAyL1cHE1zuTCNtS2qD-TxqXT-jvqbPRzgTcCtz2CZ_Pc130_assertion SIO_000772 21934105 NP925197.RAyL1cHE1zuTCNtS2qD-TxqXT-jvqbPRzgTcCtz2CZ_Pc130_provenance.
- NP925197.RAyL1cHE1zuTCNtS2qD-TxqXT-jvqbPRzgTcCtz2CZ_Pc130_assertion wasDerivedFrom befree-2016 NP925197.RAyL1cHE1zuTCNtS2qD-TxqXT-jvqbPRzgTcCtz2CZ_Pc130_provenance.
- NP925197.RAyL1cHE1zuTCNtS2qD-TxqXT-jvqbPRzgTcCtz2CZ_Pc130_assertion wasGeneratedBy ECO_0000203 NP925197.RAyL1cHE1zuTCNtS2qD-TxqXT-jvqbPRzgTcCtz2CZ_Pc130_provenance.